Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-crystallin as a molecular chaperone.

B K Derham1, J J Harding

  • 1Nuffield Laboratory of Ophthalmology, University of Oxford, UK.

Progress in Retinal and Eye Research
|April 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers.

Investigational new drugs·2021
Same author

Characterization of on-target adverse events caused by TRK inhibitor therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Comments on the role of metal-catalysed autoxidation in glycation and the Maillard reaction.

Redox report : communications in free radical research·2016
Same author

Investigation of gammaE-crystallin target protein binding to bovine lens alpha-crystallin by small-angle neutron scattering.

Biochimica et biophysica acta·2009
Same author

Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats.

Molecular vision·2008

Alpha-crystallin acts as a molecular chaperone, preventing protein aggregation in the eye lens. Its function declines with age and post-translational modifications, potentially linking to cataract development and therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Ophthalmology

Background:

  • Alpha-crystallin functions as a molecular chaperone, crucial for maintaining lens transparency by preventing protein aggregation.
  • It protects enzyme activities and interacts with unfolded proteins in a molten globule state, primarily early in denaturation.
  • The amphiphilic nature of alpha-crystallin, with polar C-terminal and hydrophobic N-terminal regions, is vital for its chaperone activity.

Purpose of the Study:

  • To elucidate the mechanism of alpha-crystallin's molecular chaperone function.
  • To investigate the age-dependent changes and post-translational modifications affecting alpha-crystallin's chaperone activity.
  • To explore the potential of alpha-crystallin as a therapeutic target for conformational disorders like cataract.

Main Methods:

Related Experiment Videos

  • Analysis of protein interactions and denaturation pathways.
  • Cryo-electron microscopy (cryo-EM) to determine 3D structure.
  • Assessment of chaperone function in alpha-crystallin from lens nuclei of varying ages and conditions.
  • Evaluation of the impact of post-translational modifications (glycation, carbamylation, oxidation, etc.) on chaperone activity.

Main Results:

  • Alpha-crystallin prevents aggregation by trapping unfolded proteins in high molecular weight complexes.
  • Cryo-EM revealed a variable 3D structure with a hollow interior, supporting its function.
  • Chaperone function decreases with age and is reduced in high molecular weight aggregates found in cataractous lenses.
  • Post-translational modifications significantly impair alpha-crystallin's chaperone capabilities.

Conclusions:

  • Alpha-crystallin's molecular chaperone activity is essential for lens transparency.
  • Age-related decline and post-translational modifications compromise its function, contributing to cataract formation.
  • AlphaB-crystallin's expression outside the lens and in pathological states suggests broader roles and therapeutic potential for conformational disorders.